SHOCKWAVE MED INC's ticker is SWAV and the CUSIP is 82489T104. A total of 235 filers reported holding SHOCKWAVE MED INC in Q2 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,089 | -11.7% | 256,600 | +26.5% | 0.09% | +4.8% |
| Q2 2023 | $57,881 | +36.1% | 202,800 | +3.4% | 0.08% | +48.2% |
| Q1 2023 | $42,542 | -48.6% | 196,200 | -51.3% | 0.06% | -50.4% |
| Q4 2022 | $82,779 | -99.9% | 402,600 | +24.8% | 0.11% | -11.0% |
| Q3 2022 | $89,733,000 | +986.5% | 322,700 | +647.0% | 0.13% | +1170.0% |
| Q2 2022 | $8,259,000 | +323.8% | 43,200 | +359.6% | 0.01% | +400.0% |
| Q1 2022 | $1,949,000 | -79.2% | 9,400 | -82.1% | 0.00% | -83.3% |
| Q4 2021 | $9,362,000 | -28.1% | 52,500 | -16.9% | 0.01% | -29.4% |
| Q3 2021 | $13,012,000 | -32.6% | 63,200 | -37.9% | 0.02% | -29.2% |
| Q2 2021 | $19,296,000 | +2208.1% | 101,700 | +303.6% | 0.02% | +2300.0% |
| Q1 2020 | $836,000 | -81.6% | 25,200 | -83.4% | 0.00% | -75.0% |
| Q3 2019 | $4,543,000 | -26.0% | 151,790 | +41.1% | 0.00% | -20.0% |
| Q2 2019 | $6,143,000 | – | 107,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prossimo Advisors, LLC | 18,758 | $3,735 | 8.81% |
| Matisse Capital | 22,175 | $4,415,043 | 3.12% |
| Atika Capital Management LLC | 116,500 | $23,195,150 | 3.04% |
| APEIRON CAPITAL Ltd | 18,300 | $3,643,530 | 2.44% |
| AtonRa Partners | 4,374 | $870,863 | 1.83% |
| Rhenman & Partners Asset Management AB | 81,000 | $16,127,100 | 1.74% |
| GILDER GAGNON HOWE & CO LLC | 549,173 | $109,340,363 | 1.66% |
| Eversept Partners, LP | 84,462 | $16,816,384 | 1.42% |
| Biondo Investment Advisors, LLC | 37,451 | $7,456,394 | 1.40% |
| DEEPWATER ASSET MANAGEMENT, LLC | 15,321 | $3,050,411 | 1.40% |